Elevance Health, Inc. ELV
429.48 USD -0.17 (-0.04%)
At closeNov 12, 2026, 4:01 AM EST
432.48 +3.00 +0.70%
Pre-market · Nov 12, 4:01 AM ET
422.00 Day range 430.54
274.84 52-week range 450.69
- YTD
- +22.52%
- 1 year
- +36.23%
News
zacks.com ELV or RVTY: Which Is the Better Value Stock Right Now? Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Revvity (RVTY). But which of these two companies is the best option for those looking for…
benzinga.com Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492 Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $473 to $492.
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495 TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $465 to $495.
benzinga.com UBS Maintains Buy on Elevance Health, Raises Price Target to $523 UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $523.
benzinga.com Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $485 Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $485.
benzinga.com Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449 Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from $404 to $449.- benzinga.com RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $455 RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and raises the price target from $424 to $455.
- benzinga.com Barclays Maintains Overweight on Elevance Health, Raises Price Target to $472 Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $469 to $472.
benzinga.com Baird Maintains Neutral on Elevance Health, Raises Price Target to $406 Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $393 to $406.
benzinga.com Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
benzinga.com Elevance Health Q3 2026 Earnings Call Transcript Elevance Health (NYSE:ELV) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Elevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate Elevance Health (NYSE:ELV) reported quarterly earnings of $6.99 per share which beat the analyst consensus estimate of $4.68 by 49.36 percent. This is a 15.92 percent increase over earnings of $6.03…- benzinga.com Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $460 Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $455 to $460.
marketindex.com.au ASX 200 Live Today - Thursday, 12th November The S&P/ASX 200 is set to slip despite a chip-led Wall St rebound as a surging US dollar hits commodities. Here are today's ...
finance.sina.com.cn iShares 美国医疗保健供应商 ETF前十大重仓股占比73.2382%，第一大重仓股为联合健康 此外，前十大重仓股还包括HCA控股、Veeva Systems Inc. Class A、休曼纳、 信诺 、Centene Corp、Labcorp Holdings Inc. ORD和奎斯特。finance.yahoo.com ELV or RVTY: Which Is the Better Value Stock Right Now? We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in ...
finance.yahoo.com Stocks Surge on AI Demand Optimism The S&P 500 Index ($SPX ) (SPY ) is up +1.16% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.15%, and the ...
kalkine.com.au Pacific Current Group Reports Debt-Free Balance Sheet and Strategic Review Update at 2026 AGM Pacific Current Group (ASX:PAC) disclosed at its 2026 Annual General Meeting on 12 November 2026 that the company has repaid ...
theglobeandmail.com Can HUM's New Oncology Model Strengthen Its Value-Based Care Strategy? HUM is expanding its efforts to improve care delivery and manage treatment costs through a new oncology partnership with ...
kalkine.com.au Why investment holding company Queste Communications (ASX:QUE) is asking shareholders to approve leaving the ASX Why investment holding company Queste Communications (ASX:QUE) is asking shareholders to approve leaving the ASX ...
kalkine.com.au Why engineering and defence technology firm Hydrix (ASX:HYD) is asking shareholders to convert director loans into equity Why engineering and defence technology firm Hydrix (ASX:HYD) is asking shareholders to convert director loans into equity ...
msn.com Evening wrap: ASX 200 nears record high as banks and healthcare rally – gold, lithium and uranium stocks plummet The S&P/ASX 200 closed 6.4 points lower, down 0.07%.